We showed that elevated GADD45B expression in MM cells correlates with poor clinical outcome and promotes malignant cell survival by suppressing JNK-driven apoptosis through a mechanism that depends upon the GADD45β-mediated binding to and inhibition of MKK7 [11,21]. The gene discussed is MAP2K7; the disease is Miyoshi myopathy.